BioNews is a health media company focused on rare diseases and rare patient experiences. BioNews provides an insider’s view into disease and treatment news, condition management information, and community across more than 60+ diseases. A fierce champion of the rare voice, BioNews content is designed to reach, engage, and elevate even the smallest patient populations. We’re the only rare news and information property in the U.S. and are committed to the insider’s view into a rare disease or experience. People turn to our content for timely treatment news, management, community and to identify clinical trials opportunities that are a right match for them.